Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Mélanie Drolet, Élodie Bénard, Marie‐Claude Boily, et al.
The Lancet Infectious Diseases (2015) Vol. 15, Iss. 5, pp. 565-580
Open Access | Times Cited: 594

Showing 1-25 of 594 citing articles:

Cervical cancer
Paul A. Cohen, A. Jhingran, Ana Oaknin, et al.
The Lancet (2019) Vol. 393, Iss. 10167, pp. 169-182
Closed Access | Times Cited: 1903
Sexually Transmitted Infections Treatment Guidelines, 2021
Kimberly Workowski, Laura H. Bachmann, Philip A. Chan, et al.
MMWR Recommendations and Reports (2021) Vol. 70, Iss. 4, pp. 1-187
Open Access | Times Cited: 1589
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei, Alexander Ploner, K. Miriam Elfström, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 14, pp. 1340-1348
Open Access | Times Cited: 1057
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Mélanie Drolet, Élodie Bénard, Norma Pérez, et al.
The Lancet (2019) Vol. 394, Iss. 10197, pp. 497-509
Open Access | Times Cited: 1046
Cancer of the cervix uteri
Neerja Bhatla, Daisuke Aoki, Daya Nand Sharma, et al.
International Journal of Gynecology & Obstetrics (2018) Vol. 143, Iss. S2, pp. 22-36
Open Access | Times Cited: 965
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins, Richard S. Guido, Philip E. Castle, et al.
Journal of Lower Genital Tract Disease (2020) Vol. 24, Iss. 2, pp. 102-131
Open Access | Times Cited: 954
Carcinogenic human papillomavirus infection
Mark Schiffman, John Doorbar, Nicolas Wentzensen, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Closed Access | Times Cited: 848
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
Laia Bruni, Mireia Díaz, Leslie Barrionuevo-Rosas, et al.
The Lancet Global Health (2016) Vol. 4, Iss. 7, pp. e453-e463
Open Access | Times Cited: 730
Human Papillomavirus–Associated Cancers — United States, 2008–2012
Laura Viens, S. Jane Henley, Meg Watson, et al.
MMWR Morbidity and Mortality Weekly Report (2016) Vol. 65, Iss. 26, pp. 661-666
Open Access | Times Cited: 724
Cancer of the cervix uteri
Adriana Bermúdez, Neerja Bhatla, Eric Leung
International Journal of Gynecology & Obstetrics (2015) Vol. 131, Iss. S2
Open Access | Times Cited: 644
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Marc Arbyn, Lan Xu, Cindy Simoens, et al.
Cochrane library (2018) Vol. 2020, Iss. 3
Open Access | Times Cited: 517
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Nagayasu Egawa, Kiyofumi Egawa, Heather Griffin, et al.
Viruses (2015) Vol. 7, Iss. 7, pp. 3863-3890
Open Access | Times Cited: 506
Epidemiology and burden of HPV-related disease
Beatriz Serrano, María Brotons, F. Xavier Bosch, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2017) Vol. 47, pp. 14-26
Closed Access | Times Cited: 486
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Suzanne M. Garland, Susanne K. Kjær, Nubia Muñóz, et al.
Clinical Infectious Diseases (2016) Vol. 63, Iss. 4, pp. 519-527
Open Access | Times Cited: 437
Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives
Chee Kai Chan, Gulzhanat Aimagambetova, Talshyn Ukybassova, et al.
Journal of Oncology (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 414
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
Warner K. Huh, Elmar A. Joura, Anna R. Giuliano, et al.
The Lancet (2017) Vol. 390, Iss. 10108, pp. 2143-2159
Open Access | Times Cited: 401
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Zoé Apalla, Dorothée Nashan, Richard Weller, et al.
Dermatology and Therapy (2017) Vol. 7, Iss. S1, pp. 5-19
Open Access | Times Cited: 390
Surveillance of Vaccination Coverage among Adult Populations — United States, 2015
Walter W. Williams, Peng–jun Lu, Alissa O’Halloran, et al.
MMWR Surveillance Summaries (2017) Vol. 66, Iss. 11, pp. 1-28
Open Access | Times Cited: 380
HPV vaccines – A review of the first decade
Diane M. Harper, Leslie R. DeMars
Gynecologic Oncology (2017) Vol. 146, Iss. 1, pp. 196-204
Open Access | Times Cited: 376
Prevalence of HPV After Introduction of the Vaccination Program in the United States
Lauri E. Markowitz, Liu Gui, Susan Hariri, et al.
PEDIATRICS (2016) Vol. 137, Iss. 3
Open Access | Times Cited: 357
Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B.S. Roden, Peter L. Stern
Nature reviews. Cancer (2018) Vol. 18, Iss. 4, pp. 240-254
Open Access | Times Cited: 290
The low-risk papillomaviruses
Nagayasu Egawa, John Doorbar
Virus Research (2016) Vol. 231, pp. 119-127
Open Access | Times Cited: 282
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
Marc Brisson, Élodie Bénard, Mélanie Drolet, et al.
The Lancet Public Health (2016) Vol. 1, Iss. 1, pp. e8-e17
Open Access | Times Cited: 271
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Cyra Patel, Julia Brotherton, Alexis Pillsbury, et al.
Eurosurveillance (2018) Vol. 23, Iss. 41
Open Access | Times Cited: 252
Evidence for underuse of effective medical services around the world
Paul Glasziou, Sharon E. Straus, Shannon Brownlee, et al.
The Lancet (2017) Vol. 390, Iss. 10090, pp. 169-177
Closed Access | Times Cited: 237
Page 1 - Next Page

Scroll to top